The dangers of clogged arteries extend well beyond the workings of your heart. Peripheral artery disease makes it difficult ...

The Miami Lakes, Florida-based company presented 12-month results from the SUCCESS PTA study at the Charing Cross Symposium ...

Limus-based devices, rather than being a substitute for paclitaxel as they were once seen, are coming of age in peripheral ...

A new minimally invasive procedure is offering hope to patients suffering from Peripheral Artery Disease (PAD) in San Antonio.The procedure, whic ...

R3 Vascular announced that a doctor treated the first patient in the ELITE-BTK pivotal trial of its drug-eluting ...

After making a $2.5 million investment in Cleveland-based University Hospitals Harrington’s Heart & Vascular Institute at the UH Portage Medical Center, which included establishing a catheterization ...

Efemoral Medical announced the presentation of long-term results from the initial 20 patients enrolled across four sites in ...

UK: A Mendelian randomization study published in the Journal of the American College of Cardiology identified elevated ...

A case study on intravascular lithotripsy for the treatment of calcified carotid disease to demonstrate technical feasibility ...

The global peripheral vascular devices market, valued at USD 4.7 billion in 2022, is projected to expand at a robust CAGR of 6.6%, reaching USD 8.9 billion by 2032, according to Future Market Insights ...